PMID- 25082846 OWN - NLM STAT- MEDLINE DCOM- 20150610 LR - 20140926 IS - 1755-3245 (Electronic) IS - 0008-6363 (Linking) VI - 104 IP - 1 DP - 2014 Oct 1 TI - Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase. PG - 15-23 LID - 10.1093/cvr/cvu174 [doi] AB - AIMS: Inducible gene targeting in mice using the Cre/LoxP system has become a valuable tool to analyse the roles of specific genes in the adult heart. However, the commonly used Myh6-MerCreMer system requires time-consuming breeding schedules and is potentially associated with cardiac side effects, which may result in transient cardiac dysfunction. The aim of our study was to establish a rapid and simple system for cardiac gene inactivation in conditional knockout mice by gene transfer of a Cre recombinase gene using adeno-associated viral vectors of serotype 9 (AAV9). METHODS AND RESULTS: AAV9 vectors expressing Cre under the control of a human cardiac troponin T promoter (AAV-TnT-Cre) enabled a highly efficient Cre/LoxP switching in cardiomyocytes 2 weeks after injection into 5- to 6-week-old ROSA26-LacZ reporter mice. Recombination efficiency was at least as high as observed with the Myh6-MerCreMer system. No adverse side effects were detected upon application of AAV-TnT-Cre. As proof of principle, we studied AAV-TnT-Cre in a conditional knockout model (Srf-flex1 mice) to deplete the myocardium of the transcription factor serum response factor (SRF). Four weeks after AAV-TnT-Cre injection, a strong decrease in the cardiac expression of SRF mRNA and protein was observed. Furthermore, mice developed a severe cardiac dysfunction with increased interstitial fibrosis in accordance with the central role of SRF for the expression of contractile and calcium trafficking proteins in the heart. CONCLUSIONS: AAV9-mediated expression of Cre is a promising approach for rapid and efficient conditional cardiac gene knockout in adult mice. CI - Published on behalf of the European Society of Cardiology. All rights reserved. (c) The Author 2014. For permissions please email: journals.permissions@oup.com. FAU - Werfel, Stanislas AU - Werfel S AD - Department of Internal Medicine III, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany Institute for Pharmacology and Toxicology, Technische Universitat Munchen, Biedersteiner Str. 29, Munich 80802, Germany DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. FAU - Jungmann, Andreas AU - Jungmann A AD - Department of Internal Medicine III, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany. FAU - Lehmann, Lorenz AU - Lehmann L AD - Department of Internal Medicine III, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Germany. FAU - Ksienzyk, Jan AU - Ksienzyk J AD - Department of Internal Medicine III, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany. FAU - Bekeredjian, Raffi AU - Bekeredjian R AD - Department of Internal Medicine III, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Germany. FAU - Kaya, Ziya AU - Kaya Z AD - Department of Internal Medicine III, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Germany. FAU - Leuchs, Barbara AU - Leuchs B AD - Applied Tumorvirology, German Cancer Research Center, Heidelberg, Germany. FAU - Nordheim, Alfred AU - Nordheim A AD - Interfaculty Institute for Cell Biology, Department of Molecular Biology, University of Tubingen, Tubingen, Germany. FAU - Backs, Johannes AU - Backs J AD - Department of Internal Medicine III, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Germany. FAU - Engelhardt, Stefan AU - Engelhardt S AD - Institute for Pharmacology and Toxicology, Technische Universitat Munchen, Biedersteiner Str. 29, Munich 80802, Germany DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. FAU - Katus, Hugo A AU - Katus HA AD - Department of Internal Medicine III, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Germany. FAU - Muller, Oliver J AU - Muller OJ AD - Department of Internal Medicine III, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg 69120, Germany DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Germany oliver.mueller@med.uni-heidelberg.de o.mueller@dkfz-heidelberg.de. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140731 PL - England TA - Cardiovasc Res JT - Cardiovascular research JID - 0077427 RN - 0 (Gt(ROSA)26Sor non-coding RNA, mouse) RN - 0 (RNA, Messenger) RN - 0 (RNA, Untranslated) RN - 0 (Serum Response Factor) RN - 0 (Troponin T) RN - EC 2.7.7.- (Cre recombinase) RN - EC 2.7.7.- (Integrases) SB - IM CIN - Cardiovasc Res. 2014 Oct 1;104(1):3-4. PMID: 25187523 MH - Animals MH - Cardiomyopathies/genetics/metabolism/pathology/physiopathology MH - Dependovirus/enzymology/*genetics MH - Down-Regulation MH - Fibrosis MH - *Gene Knockdown Techniques MH - Genotype MH - Integrases/biosynthesis/*genetics MH - Lac Operon MH - Male MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Myocytes, Cardiac/*metabolism/pathology MH - Phenotype MH - Promoter Regions, Genetic MH - RNA, Messenger/metabolism MH - RNA, Untranslated/genetics MH - Serum Response Factor/genetics/metabolism MH - Time Factors MH - Troponin T/genetics MH - Ventricular Dysfunction, Left/genetics/metabolism/pathology/physiopathology MH - Ventricular Function, Left OTO - NOTNLM OT - Adeno-associated virus OT - Cardiomyopathy OT - Conditional transgenic mouse OT - Gene regulation OT - Serum response factor EDAT- 2014/08/02 06:00 MHDA- 2015/06/11 06:00 CRDT- 2014/08/02 06:00 PHST- 2014/08/02 06:00 [entrez] PHST- 2014/08/02 06:00 [pubmed] PHST- 2015/06/11 06:00 [medline] AID - cvu174 [pii] AID - 10.1093/cvr/cvu174 [doi] PST - ppublish SO - Cardiovasc Res. 2014 Oct 1;104(1):15-23. doi: 10.1093/cvr/cvu174. Epub 2014 Jul 31.